Ganapathy Viswanathan, Communication Consultant & Author, writes how fragmented audiences and digital consumption are ...

Silicon photonics manufacturing depends on accurate positioning and alignment to support device performance, testing, and ...

Jan. 14, 2025 A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings ...

Multiple myeloma is the second most commonly diagnosed type of blood cancer (after lymphoma). But it’s still relatively uncommon. Around the world, there were about 188,000 new cases in 2025. That ...

Multiple sclerosis (MS) is a chronic autoimmune disease that impacts the central nervous system, disrupting the flow of information between your brain and body. Symptoms range widely but can include ...

Eighteen new GNU releases in the last month (as of June 30, 2026): apl-2.0: GNU APL is a free interpreter for the programming language APL. It is an implementation of the ISO stan ...

Plasmapheresis is an uncommon treatment that can be used to manage something called myeloma kidney, a type of kidney failure that affects many people with multiple myeloma. It separates out plasma ...

Sign up for the daily CJR newsletter. Objectivity hasn’t always been a cornerstone of journalism. American publishers first turned to objectivity in the early ...

Dwyer et al. apply multi-contrast post-processing and deep learning to standard MRI scans from a large multiple sclerosis clinical trial to quantify cortical lesions. They show that combining enhanced ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas including investing, ...

Blood tests can’t confirm multiple sclerosis (MS), but they help rule out other conditions with similar symptoms like Lyme disease, lupus, anemia, thyroid disease, and vitamin deficiencies. Doctors ...